Immediate Impact
1 by Nobel laureates 50 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Radiopharmaceuticals and their applications in medicine
2025 Standout
Works of Suzanne C. van Es being referenced
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
2019
89 Zr-bevacizumab PET imaging in metastatic renal cell carcinoma patients before and during antiangiogenic treatment.
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Suzanne C. van Es | 138 | 221 | 155 | 14 | 387 | |
| K Adams | 105 | 150 | 131 | 14 | 427 | |
| George Horng | 89 | 91 | 140 | 9 | 336 | |
| Nancy S. Scher | 91 | 123 | 270 | 8 | 407 | |
| Lodovica Zullo | 211 | 137 | 186 | 22 | 370 | |
| C.P. Schröder | 62 | 137 | 175 | 16 | 372 | |
| K. L. Blackwell | 100 | 89 | 304 | 15 | 427 | |
| Sara Grehl | 178 | 183 | 110 | 10 | 422 | |
| Jurui Luo | 95 | 108 | 156 | 21 | 399 | |
| Stephanie Sutherland | 158 | 81 | 198 | 17 | 366 | |
| Matthew P. Miller | 106 | 279 | 105 | 10 | 422 |
All Works
Login with ORCID to disown or claim papers
Loading papers...